The most common class of medications used to treat osteoporosis is antiresorptive drugs. Common side effects include heartburn, nausea, and trouble swallowing. Osteoporosis is a disease characterized ...

From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few ...

Bactrim commonly causes mild reactions like nausea and diarrhea, which typically resolve after treatment ends or within a few days of the last dose. Serious complications can occur, including severe ...

As with other drugs, ondansetron can cause side effects, such as fatigue, headache, and constipation. If side effects of ondansetron become difficult to tolerate, talk with your doctor or pharmacist.

Leflunomide is a generic drug prescribed for rheumatoid arthritis in adults. As with other drugs, leflunomide can cause side effects, such as eye problems and skin rash. Leflunomide is available as ...

If your doctor recently prescribed Repatha to help lower your "bad" LDL cholesterol and reduce the risk of heart disease, you may be wondering how it fits into the bigger picture of heart health.

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can increase the risk of secondary tumors in the uterus. The study shows that ...

There’s a balance required to manage both the symptoms of myelofibrosis through treatment and the side effects caused by the drugs, explained Firas El Chaer, MD, of the University of Virginia School ...

Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments. However, about half of the patients who take these drugs stop within a year because of unwanted side effects. 1,2 For ...

For people with obesity or type 2 diabetes, glucagon-like peptide 1 (GLP-1) agonists (including Mounjaro, Wegovy, and Ozempic) have been labeled miracle drugs. But they aren’t miraculous for everyone.

Rosie O'Donnell says taking a gradual approach to weight loss through GLP-1 drug Mounjaro helped her avoid the common side ...